In CBF AML, mutations inc-KITmay be associated with worse outcome in some studies47,48,49,50, but not with fludarabine-cytarabine-GO-based regimens12,13,14. Investigating the addition of a potent c-KIT inhibitor
promising results. To achieve optimal results in such a rare and heterogeneous entity as AML requires expertise, familiarity with this rare cancer, and the access to, and delivery of disparate therapies under rigorous supportive care conditions. In this review, we update the standard-of-care and ...
Blood cancer is the most common type of cancer and the leading cause of death by disease past infancy among children. Children with blood cancer are vulner
2023, 187, 106297. [Google Scholar] [CrossRef] [PubMed] Jiang, Y.; Zhang, H.; Wang, J.; Liu, Y.; Luo, T.; Hua, H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J. Hematol. Oncol. 2022, 15, 34. [Google Scholar] [CrossRef] [PubMed...
Patients with renal cell carcinoma and thyroid cancer have high incidence of sorafenib-associated all grade hypertension.Aug 27, 2015 Click here to read the entire abstract Pubmed Data : Am J Ther. 2015 Aug 28. Epub 2015 Aug 28. PMID: 26322676 Article Published Date : Aug 27, 2015 Study...
A total of 54 patients who underwent radial artery catheterization via thoracoscopic surgery at the Affiliated Cancer Hospital of Fudan University were enrolled from Dec 2nd, 2022, to Apr 1st, 2023. The patient underwent one-lung ventilation during surgery. The ABGA values were evaluated by the ...
A 2023 study found that using these drugs for one to three years was associated with a 58 percent increased risk of all thyroid cancers, and a 78 percent increased risk of medullary thyroid cancer.[18] As a pharmacist who has dedicated my life’s work to thyroid health, I can’t help ...
Leons GK, Sharma P, Gupta SK, Gupta R, Rani L, Gajendra S et al (2023) Detection of a novel SNX2 gene breakpoint in the SNX2::ABL1 fusion transcript in Ph-like B-cell acute lymphoblastic leukemia. Pediatr Blood Cancer e30546. https://doi.org/10.1002/pbc.30546 Tanasi I, Ba N...
diabetes, coronary heart disease, chronic obstructive pulmonary disease, chronic bronchitis, cerebral infarction, major surgeries within the last 12 months, renal failure, cancer, depression, corticosteroid use, smoking, drinking, and blood type, along with perioperative blood transfusion-related variables....
high-quality PRO data from cancer registrational trials can be communicated to the public. FDA has described a core outcome set to be included in cancer clinical trials, which includes assessment of patient-reported adverse events, disease symptoms, physical function, role function, and overall side...